Guggenheim Maintains Merck at Buy, Raises Price Target to $171
Guggenheim raised its price target from $170 to $171. The new target implies 16.9% upside from Merck's Oct. 29 close of $146.33.
Guggenheim raised its price target from $170 to $171. The new target implies 16.9% upside from Merck's Oct. 29 close of $146.33.